Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Allergy|July 1, 2022
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbationSarah Diver, Koirobi Haldar, Pamela Jane McDowell, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
The Lancet. Respiratory Medicine|March 27, 2022
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trialAhmed J Yousuf, Seid Mohammed, Liesl Carr, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2024
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA StudyRatko Djukanović, Paul Brinkman, Johan Kolmert, et al.
The European Respiratory Journal|May 28, 2016
Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomographyDeepak R Subramanian, Sumit Gupta, Dorothe Burggraf, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trialHolly R Keir, Merete B Long, Hani Abo-Leyah, et al.
The European Respiratory Journal|March 15, 2023
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVIDNicholas A Scott, Laurence Pearmain, Sean B Knight, et al.
The European Respiratory Journal|February 20, 2025
Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): a randomised controlled trial of exercise-based rehabilitationEnya Daynes, Rachael A Evans, Neil J Greening, et al.
Ebiomedicine|December 21, 2022
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Shubha Talwar, Andy Cross, et al.
Trials|January 26, 2023
The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortiumEnya Daynes, Molly Baldwin, Neil J Greening, et al.
Pageof 8